Northern Trust’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5M | Sell |
1,539,181
-41,646
| -3% | -$402K | ﹤0.01% | 1734 |
|
|
2026
Q1 | $11.7M | Buy |
1,580,827
+157,739
| +11% | +$1.66M | ﹤0.01% | 1989 |
|
|
2025
Q4 | $16.7M | Sell |
1,423,088
-66,593
| -4% | -$718K | ﹤0.01% | 1787 |
|
|
2025
Q3 | $11.5M | Buy |
1,489,681
+11,916
| +0.8% | +$83.5K | ﹤0.01% | 2031 |
|
|
2025
Q2 | $10.8M | Sell |
1,477,765
-97,103
| -6% | -$784K | ﹤0.01% | 2030 |
|
|
2025
Q1 | $14.9M | Sell |
1,574,868
-46,941
| -3% | -$586K | ﹤0.01% | 1807 |
|
|
2024
Q4 | $26.7M | Buy |
1,621,809
+111,170
| +7% | +$1.73M | ﹤0.01% | 1508 |
|
|
2024
Q3 | $22.3M | Buy |
1,510,639
+24,128
| +2% | +$378K | ﹤0.01% | 1555 |
|
|
2024
Q2 | $20.6M | Sell |
1,486,511
-40,705
| -3% | -$577K | ﹤0.01% | 1543 |
|
|
2024
Q1 | $24M | Sell |
1,527,216
-71,424
| -4% | -$1.1M | ﹤0.01% | 1464 |
|
|
2023
Q4 | $25.9M | Buy |
1,598,640
+22,498
| +1% | +$368K | ﹤0.01% | 1439 |
|
|
2023
Q3 | $19.4M | Buy |
1,576,142
+828
| +0.1% | +$12.3K | ﹤0.01% | 1565 |
|
|
2023
Q2 | $25.3M | Buy |
1,575,314
+26,107
| +2% | +$430K | ﹤0.01% | 1431 |
|
|
2023
Q1 | $27M | Sell |
1,549,207
-7,309
| -0.5% | -$104K | 0.01% | 1357 |
|
|
2022
Q4 | $14.4M | Sell |
1,556,516
-84,557
| -5% | -$788K | ﹤0.01% | 1763 |
|
|
2022
Q3 | $14.1M | Buy |
1,641,073
+382,486
| +30% | +$3.8M | ﹤0.01% | 1729 |
|
|
2022
Q2 | $10.3M | Sell |
1,258,587
-246,477
| -16% | -$2.35M | ﹤0.01% | 2013 |
|
|
2022
Q1 | $18.3M | Sell |
1,505,064
-47,672
| -3% | -$1M | ﹤0.01% | 1745 |
|
|
2021
Q4 | $53M | Sell |
1,552,736
-14,265
| -0.9% | -$559K | 0.01% | 1047 |
|
|
2021
Q3 | $75.6M | Sell |
1,567,001
-15,463
| -1% | -$716K | 0.01% | 807 |
|
|
2021
Q2 | $71.5M | Buy |
1,582,464
+13,068
| +0.8% | +$579K | 0.01% | 853 |
|
|
2021
Q1 | $75.7M | Buy |
1,569,396
+20,346
| +1% | +$1.06M | 0.01% | 817 |
|
|
2020
Q4 | $83.4M | Sell |
1,549,050
-789
| -0.1% | -$35.7K | 0.02% | 725 |
|
|
2020
Q3 | $57.2M | Sell |
1,549,839
-67,825
| -4% | -$2.52M | 0.01% | 829 |
|
|
2020
Q2 | $50.1M | Buy |
1,617,664
+146,388
| +10% | +$4.06M | 0.01% | 895 |
|
|
2020
Q1 | $40.6M | Sell |
1,471,276
-117,944
| -7% | -$3.53M | 0.01% | 894 |
|
|
2019
Q4 | $46.5M | Sell |
1,589,220
-41,339
| -3% | -$984K | 0.01% | 1074 |
|
|
2019
Q3 | $31.2M | Buy |
1,630,559
+187,806
| +13% | +$4.41M | 0.01% | 1327 |
|
|
2019
Q2 | $31.7M | Buy |
1,442,753
+63,660
| +5% | +$1.4M | 0.01% | 1347 |
|
|
2019
Q1 | $28.2M | Buy |
1,379,093
+245,101
| +22% | +$4.26M | 0.01% | 1408 |
|
|
2018
Q4 | $14.3M | Sell |
1,133,992
-10,954
| -1% | -$163K | ﹤0.01% | 1841 |
|
|
2018
Q3 | $17.6M | Buy |
1,144,946
+146,139
| +15% | +$2.02M | ﹤0.01% | 1889 |
|
|
2018
Q2 | $13.1M | Buy |
998,807
+21,293
| +2% | +$234K | ﹤0.01% | 2076 |
|
|
2018
Q1 | $7.98M | Buy |
977,514
+12,920
| +1% | +$105K | ﹤0.01% | 2317 |
|
|
2017
Q4 | $8.55M | Sell |
964,594
-15,890
| -2% | -$147K | ﹤0.01% | 2287 |
|
|
2017
Q3 | $10.9M | Buy |
980,484
+643
| +0.1% | +$6.26K | ﹤0.01% | 2144 |
|
|
2017
Q2 | $8.78M | Buy |
979,841
+94,277
| +11% | +$748K | ﹤0.01% | 2263 |
|
|
2017
Q1 | $6.99M | Buy |
885,564
+12,589
| +1% | +$103K | ﹤0.01% | 2351 |
|
|
2016
Q4 | $7.48M | Sell |
872,975
-23,924
| -3% | -$205K | ﹤0.01% | 2292 |
|
|
2016
Q3 | $7.37M | Buy |
896,899
+15,759
| +2% | +$132K | ﹤0.01% | 2264 |
|
|
2016
Q2 | $7.08M | Buy |
881,140
+96,385
| +12% | +$773K | ﹤0.01% | 2246 |
|
|
2016
Q1 | $5.17M | Buy |
784,755
+16,921
| +2% | +$111K | ﹤0.01% | 2390 |
|
|
2015
Q4 | $6.04M | Buy |
767,834
+105,266
| +16% | +$771K | ﹤0.01% | 2348 |
|
|
2015
Q3 | $3.8M | Buy |
662,568
+518,946
| +361% | +$3.21M | ﹤0.01% | 2620 |
|
|
2015
Q2 | $776K | Buy |
143,622
+36,104
| +34% | +$186K | ﹤0.01% | 3432 |
|
|
2015
Q1 | $502K | Hold |
107,518
| – | – | ﹤0.01% | 3608 |
|
|
2014
Q4 | $448K | Sell |
107,518
-7,685
| -7% | -$35.3K | ﹤0.01% | 3579 |
|
|
2014
Q3 | $600K | Sell |
115,203
-246,917
| -68% | -$1.27M | ﹤0.01% | 3529 |
|
|
2014
Q2 | $1.2M | Sell |
362,120
-99,341
| -22% | -$330K | ﹤0.01% | 3331 |
|
|
2014
Q1 | $1.6M | Buy |
461,461
+8,229
| +2% | +$30.8K | ﹤0.01% | 3238 |
|
|
2013
Q4 | $1.64M | Buy |
453,232
+9,541
| +2% | +$33.1K | ﹤0.01% | 3237 |
|
|
2013
Q3 | $1.33M | Buy |
443,691
+265,344
| +149% | +$748K | ﹤0.01% | 3258 |
|
|
2013
Q2 | $710K | Buy |
+178,347
| New | +$680K | ﹤0.01% | 3369 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Northern Trust's NEO Position: Q2 2026 in Review
Northern Trust reduced its NeoGenomics (NEO) stake by 2.6% in Q2 2026, selling an estimated $402K and leaving 1,539,181 shares worth $22.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1734.
Northern Trust first reported a position in NEO in Q2 2013 and has held it in 53 quarters since. The position peaked at $83.4M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Northern Trust held 1,539,181 shares of NeoGenomics worth $22.5M as of Q2 2026.
- Northern Trust sold 41,646 NeoGenomics shares in Q2 2026, an estimated $402K.
- NeoGenomics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1734 holding.
- Northern Trust first reported a position in NeoGenomics in Q2 2013 and has held it in 53 quarters since.
- Northern Trust's NeoGenomics position peaked at $83.4M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.